Article

FDA Drug Approval Rates Highlight AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles from The American Journal of Pharmacy Benefits.

Related Videos
Image credit: Dr_Microbe | stock.adobe.com
1 expert is featured in this series.
Related Content
Atlanta, GA, USA - June 15, 2022: Closeup of the CDC logo seen at the Edward R. Roybal campus, the headquarters of the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.
June 2nd 2025

CDC Clarifies That Kids May Receive COVID-19 Vaccine Through Shared Clinical Decision-Making

Luke Halpern, Assistant Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Woman with pain from UTI -- Image credit: eddows | stock.adobe.com
June 2nd 2025

Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in cUTIs Ends Early After Meeting Primary End Point

Gillian McGovern, Associate Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Non-small cell lung cancer (NSCLC) -- Image credit: MdBabul | stock.adobe.com
June 2nd 2025

ASCO 2025: Informing Treatment Decisions Using a 14-Gene Assay in Early-Stage NSCLC

Gillian McGovern, Associate Editor David Spigel, MD
an anonymous adult man injecting himself a treatment such as insulin or Adalimumab, Etanercept or epinephrine into his shoulder. It is a white pen injector with red head for health care - Image credit: LaMorenita | stock.adobe.com
June 2nd 2025

FDA Grants Interchangeability Designation to Hadlima, a Biosimilar for Humira

Kennedy Ferruggia, Assistant Editor